Deutsch
English
Français
Español
Italiano
Svenska
Čeština
Nederlands
Русский
Українська
Polski
Ostarine (MK-2866, Enobosarm) is a selective androgen receptor modulator, or SARM. In sports, it is primarily used during cutting and recomposition phases, as well as for moderate muscle gain.
The main reason for interest in MK-2866 is the possibility of maintaining an anabolic signal in muscle tissue without using a traditional anabolic steroid. However, Ostarine can still suppress the body’s own hormonal axis, affect the lipid profile and place additional stress on the liver.
If the goal is the fastest possible increase in body mass and strength, expectations from Ostarine are often too high. Its use fits much better with the goal of preserving already developed muscle during a calorie deficit or achieving more moderate progress without expecting a dramatic change in body weight.
How Ostarine works and what effects are expected
Ostarine binds to androgen receptors and activates them, including in muscle and bone tissue. Through this mechanism, it can support anabolic processes and influence lean body mass.
MK-2866 does not aromatize into estrogens and does not convert into DHT. However, this does not mean that every change in body weight during a cycle automatically represents new muscle. Lean body mass includes more than muscle tissue, while water and glycogen levels can also change independently of aromatization.
For this reason, the result is better evaluated in the context of the specific goal. During a calorie deficit, the main question is how well previously developed muscle and overall condition are preserved. During a calorie surplus, it is more useful to assess whether there is additional progress compared with the normal response to diet and training.
What is known from human studies
Enobosarm has been studied in clinical trials, which provides more information about its effects in humans than is available for many experimental compounds. For example, a 12-week study involving 120 older men and postmenopausal women primarily evaluated changes in lean body mass and physical function. Participants did show a dose-dependent increase in lean body mass, but these findings cannot be directly converted into a prediction for a sports cycle in a young bodybuilder or used as confirmation of typical bodybuilding dosages.
Ostarine for muscle gain: how pronounced is the result?
During a calorie surplus, Ostarine is used with the expectation of additional mass gain and progress in training, but a dramatic move into a different weight category is generally not expected.
The lack of aromatization reduces the likelihood of typical estrogen-related water retention, but a number on the scale alone still cannot show how much of the gained weight represents newly developed muscle tissue. Changes in measurements, body composition and training performance are more useful for evaluating the result.
For someone whose main priority is a pronounced bulking effect, Ostarine may therefore be too moderate a tool. It is more often considered when a smaller additional gain is acceptable and there is no intention to build the cycle around the strongest possible anabolic effect.
Ostarine during cutting: does it help preserve muscle in a calorie deficit?
During a calorie deficit, the goal changes. The athlete is no longer trying to build new muscle as quickly as possible, but instead aims to lose fat while minimizing the loss of what has already been gained.
This is exactly why Ostarine is often used during cutting phases. The idea is to maintain an anabolic signal in muscle tissue during a period when fewer calories and fewer resources are available for recovery.
At the same time, MK-2866 is not a fat burner. It does not create a calorie deficit and does not by itself make the body use fat tissue significantly faster. If nutrition remains at maintenance or in a surplus, adding Ostarine does not turn that diet into a cutting phase.
The practical result during a deficit is therefore better evaluated not by how quickly body weight drops, but by how much muscle and overall condition are preserved as fat mass decreases.
How Ostarine is used: dosage, cycle length and 10 mg products
In sports practice, users often start at around 10 mg per day. A common range is approximately 10–25 mg per day, while the duration of use is usually around 6–8 weeks.
The half-life of MK-2866 is approximately one day, so it is usually taken once daily. Increasing the amount or extending the duration of the cycle also increases total exposure to the compound, so along with any potential effect, suppression of the hormonal axis and changes in laboratory markers may also become more pronounced.
Ostarine MK-2866 from Biaxol
Ostarine MK-2866 from Biaxol is available in 10 mg capsules. One package contains 60 capsules, so at 10 mg per day it lasts for 60 days. Each capsule additionally contains 5 mg of black pepper extract, which can influence the metabolism of certain substances.
MK2866 10 from Deus Medical is available as 10 mg tablets. One package contains 50 tablets, so at 10 mg per day it lasts for 50 days.
MK2866 from Astera Labs is also available as 10 mg tablets, with 50 tablets per package. In terms of concentration and total amount of active ingredient, the Deus Medical and Astera Labs options are the same, so the main difference is the brand.
Ostarine for women: specific considerations and additional risks
Women also use Ostarine in sports with the expectation of obtaining an anabolic effect without the pronounced androgenic burden associated with many steroids. However, the selectivity of a SARM does not mean that other tissues are completely unaffected.
Possible effects include acne, changes in skin oiliness, hair loss, menstrual cycle disturbances and signs of virilization. Particular attention should be paid to voice changes and other pronounced androgenic effects, as some of these changes may become permanent.
Sports dosages commonly used by men should not automatically be transferred to women. Risk depends on total exposure to the compound and individual sensitivity, while clinical studies of Enobosarm in women do not confirm the safety of bodybuilding protocols.
SARMs should not be used during pregnancy because of the potential risk to fetal development.
Ostarine side effects and what should be monitored
MK-2866 can suppress endogenous hormonal function in men. How pronounced the change becomes depends on the amount used, the duration of the cycle and individual response.
Monitoring usually focuses on:
- Testosterone, LH and FSH;
- the lipid profile, including HDL and LDL;
- liver markers;
- changes in libido and general well-being.
An increase in ALT or AST and actual drug-induced liver injury are not the same thing. However, the issue is not limited to minor laboratory abnormalities: serious cases of liver injury have also been reported with products containing SARMs.
SARMs, including Ostarine, are not approved by the FDA for sports use and have not been evaluated for safety and effectiveness as registered muscle-building drugs in healthy athletes. The FDA separately warns about possible liver injury and other serious risks associated with products in this category.
Alcohol and the simultaneous use of other potentially hepatotoxic substances add further risk factors and make changes in laboratory results more difficult to interpret.
Is PCT needed after an Ostarine cycle?
Ostarine should not be considered a non-suppressive compound. Endogenous Testosterone, LH and FSH may decrease after a cycle, and the degree of suppression cannot be predicted reliably from the dosage used alone.
However, this does not mean that every user needs the same standard PCT after MK-2866. A more reasonable approach is to plan hormonal testing in advance and assess the need for recovery therapy based on the actual post-cycle condition.
It is useful to compare Testosterone, LH and FSH with baseline values measured before the cycle. If recovery is assessed not immediately after the last tablet but after some time has passed, it becomes easier to understand whether the endogenous axis is returning on its own.
If symptoms are pronounced or suppression is significant, recovery should be discussed with a doctor, especially when fertility is a concern.
Ostarine before and after: how to evaluate the result correctly
The criteria for evaluating the result depend on why the compound was used in the first place.
During cutting, the reduction in fat mass is compared with how well the original muscle mass and training performance were preserved.
During recomposition, body weight alone provides little useful information. It is more helpful to use consistent measurements, photos taken under comparable conditions and, when available, the same method of assessing body composition.
During bulking, it makes sense to compare the changes with previous personal progress under similar nutrition and training conditions. This helps avoid interpreting every increase in body weight as a direct effect of the compound.
What Ostarine is used for in sports practice
| Goal | What is expected from MK-2866 |
| Cutting | Preserve more muscle tissue during a calorie deficit |
| Recomposition | Support muscle while gradually reducing fat mass and changing body composition |
| Bulking | Achieve a moderate additional anabolic effect alongside a calorie surplus and training |
In other words, choosing Ostarine generally makes more sense when the goal is related to preserving or moderately improving muscular condition rather than trying to achieve the fastest possible increase in total body mass.
Main conclusions on Ostarine use in sports and bodybuilding
For a bodybuilder, Ostarine makes the most sense when considered for a specific goal. During cutting, the expectation is better muscle preservation; during recomposition, support for muscle tissue while body composition changes; and during bulking, a moderate additional anabolic effect.
If the main goal is the fastest possible increase in body mass or strength, MK-2866 is unlikely to match those expectations. If the priority is preserving already developed muscle during a deficit or achieving more moderate progress, those are the scenarios in which it is more commonly used.
At the same time, a “moderate” effect does not mean an absence of risks. Before a cycle, it is useful to know baseline hormonal, lipid and liver markers, and afterward to check how endogenous hormonal function and major health markers have changed. The question of PCT should then be decided based on this overall picture rather than only on the name of the compound or subjective feelings.
